EPO Patents = 3

Forward Citations = 1

Loading Chart...

19 inventors (with patents filed for the assignee):

Shiladitya Sengupta (4 out of 21 patents)

Nimish Gupta (3 out of 3 patents)

Monideepa Roy (3 out of 7 patents)

4. Arindam Sarkar (2 out of 4 patents)

5. Pradip Dutta (2 out of 3 patents)

6. Seikh Samad Hossain (2 out of 3 patents)

7. Heeralal Bassi (1 out of 1 patent)

8. Saurabh Chitre (1 out of 3 patents)

9. Hayley Reece (1 out of 9 patents)

10. Attilia Figini (1 out of 7 patents)

11. Sarkar Arindam (1 out of 1 patent)

12. Gavin Pringle (1 out of 1 patent)

13. Ivan Ruggiero (1 out of 1 patent)

14. Sk Samad Hossain (1 out of 2 patents)

15. Aniruddha Sengupta (1 out of 3 patents)

6 patents: Sort by Forward Citations

1. 11701429 - Targeted drug delivery through affinity based linkers (2023-07-18),

2. 11554175 - Evaluation and optimization of supramolecular therapeutics (2023-01-17),

3. 11358978 - Process for preparing supramolecular platinum-based compounds (2022-06-14),

4. 10800801 - Crystalline platinum-based compounds (2020-10-13),

5. 10730899 - Lipid-based platinum compounds and nanoparticles (2020-08-04),

6. 10533059 - Targeted drug delivery through affinity based linkers (2020-01-14),

Akamara Therapeutics is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. With a pipeline of cutting-edge treatments, the company aims to address unmet medical needs and improve patients' quality of life. Through strategic partnerships and a dedicated team of experts, Akamara Therapeutics is committed to advancing breakthrough solutions in the field of neurology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#146 in Philadelphia, PA

#1,623 in Pennsylvania

#44,917 in US

Philadelphia, PA, United States of America

Akamara Therapeutics, Inc.